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Abstract
Background: Antibodies against gonadotropin-releasing hormone (GnRH) and gastrointestinal dysmotility have been 
found after treatment with GnRH analogues. The aim of this study was to examine the presence of such antibodies in 
patients with dysmotility not subjected to GnRH treatment and study the anti-GnRH antibody effect on enteric 
neurons viability in vitro.
Methods: Plasma and sera from 3 patients suffering from either enteric dysmotility, irritable bowel syndrome (IBS) or 
gastroparesis were analysed for C-reactive protein (CRP), and for GnRH antibodies and soluble CD40 by ELISA methods. 
Primary cultures of small intestinal myenteric neurons were prepared from rats. Neuronal survival was determined after 
the addition of sera either from the patients with dysmotility, from healthy blood donors, antiserum raised against 
GnRH or the GnRH analogue buserelin. Only for case 1 a full-thickness bowel wall biopsy was available for 
immunohistochemical analysis.
Results: All 3 patients expressed antibodies against GnRH. The antibody titer correlated to the levels of CD40 (rs = 
1.000, p < 0.01), but not to CRP. Serum from case 3 with highest anti-GnRH antibody titer, and serum concentrations of 
sCD40 and CRP, when added to cultured rat myenteric neurons caused remarkable cell death. In contrast, serum from 
cases 1 and 2 having lower anti-GnRH antibody titer and lower sCD40 levels had no significant effect. Importantly, 
commercial antibodies against GnRH showed no effect on neuron viability whereas buserelin exerted a protective 
effect. The full-thickness biopsy from the bowel wall of case 1 showed ganglioneuritis and decrease of GnRH and GnRH 
receptor.
Conclusion: Autoantibodies against GnRH can be detected independently on treatment of GnRH analogue. Whether 
the generation of the antibody is directly linked to neuron degeneration and chronic gastrointestinal symptoms in 
patients with intestinal dysmotility, remains to be answered.
Background
Gastrointestinal motility requires coordination between
the intrinsic and the extrinsic nervous systems, the inter-
stitial cells of Cajal (ICCs) and smooth muscle cells [1,2].
The etiology of dysmotility is in most cases unknown, but
autoimmunity or inflammation has been suggested. The
CD40 pathway is a key mediator for inflammation, and is
a marker for the active stage of some autoimmune dis-
eases [3,4].
We have recently described a patient treated with the
gonadotropin-releasing hormone (GnRH) analogue
buserelin who developed antibodies against GnRH with
ensuing degenerative neuropathy including GnRH-con-
taining enteric neurons [5]. Healthy blood donors who
served as controls did not have such antibodies [5].
Another GnRH analogue, leuprolide acetate, has been
shown to stimulate intestinal motor activity in hypophy-
sectomised and gonadectomised rats [6,7]. The same ana-
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logue has in previous studies diminished the symptoms of
nausea, vomiting and abdominal pain in irritable bowel
syndrome (IBS) [8,9].
This gave rise to the hypothesis that GnRH antibodies
may be involved also in idiopathic dysmotility diseases.
We therefore examined the expression of such antibodies
in sera from patients with gastrointestinal dysfunction
and found titers of antibodies in some patients.
The aim of this study was to further examine and
describe 3 patients suffering from severe nausea, vomit-
ing and abdominal pain, who had never been treated with
any GnRH analogues, but had nevertheless still acquired
very high titers of antibodies against GnRH, correlating
to soluble CD40 (sCD40) levels, and also had gastrointes-
tinal signs and symptoms.
Methods
The subjects were treated according to the Helsinki dec-
laration and animals were used in accordance with the
European Communities Council Directive (86/609/EEC)
and the Swedish Animal Welfare Act (SFS 1988:534). The
studies were approved by the Ethics Committee and the
Animal Ethics Committee, Lund/Malmö, respectively.
Written informed consent was obtained from the
patients.
Study Design
Blood samples were taken from patients on their initial
appointment at the Department of Gastroenterology.
Serum and plasma were separated and frozen at -20°.
Serum was analysed for anti-GnRH antibodies and
sCD40, and plasma for C-reactive protein (CRP). Serum
was further tested for its capacity to influence neuronal
survival of rat myenteric neurons in culture. Case 1
underwent a laparoscopy and histopathological examina-
tion was performed on a full-thickness wall biopsy from
the ileum.
Case 1
A 20-year old man was admitted because of nausea, vom-
iting and severe abdominal pain, accompanied by weight
loss. Besides recidivating relapses of herpes infections in
the mouth and throat, he suffered no other diseases. The
symptoms started at the age of 13 years, when he had a
sudden debut of abdominal pain and a collapse. Since
then, he suffered occasional periods of abdominal pain
and hard stools, alternating with periods of diarrhoea.
The results of tests on blood samples taken repeatedly
were all within the normal range. The diagnosis IBS was
set according to the Rome-II criteria [10]. Both his
mother and aunt suffered from functional dyspepsia since
several years; else there is no history of hereditary factors.
At the age of 18 years, the symptoms grew worse. The
most pronounced symptoms were nausea and abdominal
pain, accompanied by weight loss. The symptoms were
more and more accelerating, and the patient had difficul-
ties to manage his work and daily life. Vomiting was pres-
ent some time a week. Blood samples taken repeatedly
were all within normal ranges, inclusive cobalamines and
folate. Glutenintolerance was ruled out by negative anti-
bodies against endomysium and transglutaminase. Feces
haemoglobin was negative, suggesting intact mucosa.
Esophago-gastro-duodenoscopy (EGD) showed normal
findings in the upper gastrointestinal tract. Treatment
with histamine receptor blockers and proton pump inhib-
itors did not have any impact on the nausea.
As the routine examinations turned out normally, the
patient was referred to a psychiatric clinic for treatment.
He visited the psychologist regularly for support. How-
ever, this treatment did not affect his nausea. Because the
symptoms grew worse with abdominal pain, nausea,
impaired appetite and weight loss, and altered bowel hab-
its with constipation-dominance, he was admitted to the
Department of Gastroenterology.
The dopamine receptor antagonist metoclopramide
was then tested without any effect against the nausea.
The muscle relaxantive drug papaverin had a small effect
on abdominal pain. Further investigation with gastric
emptying scintigraphy performed after ingestion of a
meal, consisting of egg and bread, showed an emptying
rate within the highest field of the reference value. After
60 min, 55% of the content remained in the ventricle (T50
for healthy controls; 40 ± 28 min) [11].
As it was impossible for him to keep weight, also the 5-
HT3- antagonist ondansetron and the neurolepticum
prochlorperazini were tested without any result. Finally,
the dopamine receptor antagonist domperidone was pre-
scribed with good result, and the possibility of food
intake was slightly improved. As the symptoms aggra-
vated, and could not solely be explained by gastro paresis,
the patient was considered for a diagnostic laparoscopy at
the age of 23 years. This showed no macroscopic pathol-
ogy of the small intestine with a normal peristalsis. There
w e r e  n o  s i g n s  o f  a d h e s i o n s ,  M e c k e l ' s  d i v e r t i c u l u m  o r
tumours. A diamond-shaped, full-thickness wall biopsy
was taken one meter proximal to the ileocecal valve and
was immediately transported in a wet compress for path-
ological examination. The histopathological examination
showed ganglioneuritis with neuron degeneration. The
diagnosis enteric dysmotility was established based on
the clinical picture and the histopathology [12].
Case 2
A 56-year old woman, married, but without children, was
admitted because of hard stools, with several days
between stool emptying followed by diarrhoea. She also
suffered from abdominal bloating and pain, with inter-
mittent colic-attacks and nausea. Apart from analgesics,Ohlsson et al. BMC Gastroenterology 2010, 10:48
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she was taking no other medication. The symptoms
started at the age of 46 years in the form of swallowing
disturbances. She was examined with X-ray of the esoph-
agus because of these disturbances. This examination
showed quite normal findings. Three years later the pro-
cedure was repeated since the symptoms grew worse.
This showed a slightly reduced motility of the most distal
part of the esophagus. Five years later this was repeated
and also included X-ray of the hypopharynx and ventri-
cle. This examination showed normal oral and pharyn-
geal function. However, the esophagus had a normal
transport function, but a tendency to disrupted primary
peristalsis. The ventricular emptying was within normal
range. Altogether, there were signs of a slightly disturbed
esophageal function after some years of symptoms.
Examinations with EGD and colon X-ray were normal.
She got a retirement at the age of 50 years because of
headache, muscle pain and tiredness. Primary Sjögren's
syndrome was suspected because of a feeling of dryness
in mouth in combination with swallowing disturbances,
but serological markers of this disease were negative.
Besides analgesics, she had not taken any special drugs.
In addition, around the age of 50 years she was suffering
from hard stool, with several days in between stool emp-
tying. After the initial stool passage she got diarrhea. She
also suffered from a lot of gases and abdominal pain, with
intermittent colic-attacks of pain. Metoclopramide had
some effect on the swallowing disturbances, but the
patient felt best when avoiding food intake. Motility stim-
ulating laxantia was prescribed for her constipation.
After still 4-5 years the symptoms grew worse and she
was referred to the Department of Gastroenterology. The
symptoms fulfilled the Rome-II criteria for IBS [10] and
she had already gone through several examinations, why
no further investigations were performed. Metoclopr-
amide was later seponated because of cardiac arrhythmia.
The symptoms were not of such a magnitude that a full-
thickness biopsy was considered. Further, the patient had
attacks of cardiac arrhythmia which made anaesthesia
undesirable.
Case 3
A 72-year old man was admitted because of gastro paresis
and diarrhea, refractory to treatment. At the age of 1.5
y e a r s ,  h e  w a s  s i c k  f r o m  d i a b e t e s  m e l l i t u s .  H e  a q u i r e d
most of the secondary complications with nephropathy,
neuropathy and macroangiopathy with ensuing cardio-
vascular diseases. Around the age of 30 years, he started
to suffering from diarrhea and abdominal pain. Ultra
sound examinations of the abdomen performed several
times during the years were all normal. He was operated
on with nephrectomy for ureter malignancy at the age of
50 years. Postoperatively he received cytostatica in the
form of 3 periods of methotrexate, vinblastine and
CCNU, and radiation therapy. By-pass operation was per-
formed at the age of 60 years. Through the years different
immunological tests were performed, e.g. antibodies
against thyreoid, adrenal glands and gliadin. At the age of
62 years, an extensive examination was performed to
finally find out the etiology to the abdominal symptoms.
Tests for examination of bacterial overgrowth, bile salt
malabsorption and fat malabsorption were all within nor-
mal ranges. EGD revealed a light reddish mucosa. Celiaki
was ruled out trough duodenal biopsies. Enterography
revealed a dilatation and reduced motility of duodenum
and jejunum. On an initial colon X-ray a polyp was iden-
tified. Computer tomography showed a cystic change in
caput pancreatis. Gastric emptying scintigraphy showed
retention where 75% of the content remained in the ven-
tricle after 1 h. The diagnosis gastro paresis was given. A
second colon X-ray performed 2 years later revealed
diverticulosis. Different pharmacological treatment
regimes were tested through the years, i.e. erythromy-
cine, metoclopramide, cisapride, domperidone and
fibers. Metronidazole and tetracycline were tested
towards bacterial overgrowth. No one of the drugs had
any overt effect. The symptoms escalated and an EGD
was performed 8 years later which showed patchy reddish
mucosa of the ventricle. Eradication of Helicobacter
pylori did not influence the symptoms. He was eventually
referred to the Department of Gastroenterology because
of nausea, loss of appetite, early satiety, abdominal full-
ness and bloating and vomiting. He also suffered from
imperative diarrhea. He had then had peritoneal dialysis
for 3 years. The patient was deceased soon afterwards.
Antibodies
Analysis of anti-GnRH antibodies was carried out by an
ELISA method as earlier described in detail [5]. The
absorbance at 405 nm (A405) was measured in a Titertek
Multiscan at 1:40 dilution. Serum from 20 healthy blood
donors served as controls.
CD40 and CRP
CD40 was measured by an ELISA kit developed for quan-
titative detection of sCD40 in human body fluids (Alexis©
Biochemical, Bender MedSystems, Vienna, Austria). The
detection limit is 7.92 pg/ml, and the intra-assay coeffi-
cient of variation has been calculated to 5.5%. CRP was
analysed by a routine assay at the Department of Clinical
Chemistry, Skåne University Hospital, Malmö.
Cell culture
Primary cultures of small intestinal myenteric neurons
were prepared from adult female rats (n = 25), using a
modification of previously described methods [13,14].
The rats were anaesthetised, the small intestine was
exposed and longitudinal muscle with attached myentericOhlsson et al. BMC Gastroenterology 2010, 10:48
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ganglia were stripped and incubated in Ca2+ - and Mg2+ -
free Hanks' balanced salt solution (HBSS) containing col-
lagenase II (1.5 mg/ml), protease (1.5 mg/ml), trypsin
(1.25 mg/ml) and EDTA (0.01%), triturated and vortexed.
The cell suspension was centrifuged (74 g, 7 minutes),
washed in HBSS and diluted to 2 ml in Neurobasal A
(NBA), supplemented with 10% FCS, 0.5 mM glutamine,
50 U penicillin and 50 μg streptomycin sulphate per ml.
Cultures were prepared by seeding 50 μl of the cell sus-
pension together with 450 μl of NBA to each well (69
mm2) in 8-well, uncoated Tissue Culture slides (BD Fal-
con) and grown in an incubator (37°C, 5% CO2). After 4
days in vitro (DIV) 400 μl of the medium was replaced by
fresh medium and either sera or the GnRH analogue was
added (see below).
Neuronal survival was determined by cell counting
after the addition of serum from the 3 cases and 3 healthy
blood donors (dilution 1:50 -1:200), antiserum against
GnRH raised in rabbit (anti-LH-RH; PROGEN Biotech-
nik GmbH, Heidelberg, Germany; dilution 1:50-1:200) or
buserelin (10-8-10-6  M) (Suprefact©, Sanofi-Aventis,
Solna, Sweden). The agents were present for 2 days in the
cultures. At the end of this experimentation period the
cultures were fixed for 30 minutes in a mixture of 2%
formaldehyde and 0.2% picric acid in 0.1 M phosphate-
buffer, pH 7.2, followed by rinsing twice in Tyrode's solu-
tion containing 10% sucrose, and frozen until processed
for immunocytochemistry. Parallel controls were cul-
tured in NBA (supplemented as described above). As
general neuronal marker, antibodies against human pro-
tein gene product 9.5 (code no PGP9.5; Ultraclone, Isle of
Wight, UK; dilution 1:1600; [14]) were used. The surviv-
ing neurons on the entire glass cover slip were counted.
Histopathology
From the full-thickness biopsy of case 1, two transversal,
full-thickness slices perpendicular to each other were cut
and embedded in paraffin for conventional transversal
secti ons.  T he r e m ai ning,  la r g e r part  of  t he  biopsy was
embedded in toto for tangential sectioning, which makes
it possible to examine large areas of the myenteric plexus.
Serial sections from all the blocks were stained according
to a protocol for chronic intestinal pseudo-obstruction
(CIPO) analysis including a variety of antibodies [5,15].
In addition, immunostainings for herpes virus type 1 and
2 were also performed, based upon the anamnestic data
of previous herpes infection.
Furthermore, anti-GnRH antibodies (anti-LH-RH;
PROGEN Biotechnik GmbH, Heidelberg, Germany) were
applied to sections at 1:75 dilution following previous
staining for optimising the dilution (Figure 1A). The
specificity of the immunostaining was examined through
absorption of the antibody by addition of the GnRH pep-
tide (Suprefact©, Sanofi-Aventis, Bromma, Sweden)
before applying the solution to the sections. For the stain-
ing of the GnRH receptor, anti-GnRH receptor antibody
(anti-LH-RH receptor; Sigma-Aldrich, Stockholm, Swe-
den) was applied to sections at 1:100 dilution after similar
tests as with anti-GnRH antibody (Figure 1B). Negative
controls by replacing the antibody were always per-
formed together with the immunostainings. The number
of GnRH or receptor +/- neurons was counted. The num-
ber of ICCs was determined by counting ICC-nuclei both
within the intermyenteric plexus and within the circular
muscle. As controls for GnRH and GnRH receptor +/-
neurons and the number of ICCs, sections from 11 cases
of bowel resection due to small intestinal non-obliterat-
ing carcinoma with normal macro- and microscopic
appearance 10 cm above the tumour were used. The cri-
teria for enteric ganglioneuritis were described previously
[15].
Statistical methods
Histological values are expressed as mean ± standard
deviation (SD). Spearman's test was used to calculate cor-
relations. Neuronal survival in cell culture was calculated
and expressed as a percentage (mean ± standard error of
the mean; SEM) of the control run in parallel. Statistical
differences were determined using one-way analysis of
variance test (ANOVA) followed by Bonferroni's post hoc
test. P < 0.05 was considered statistically significant.
Results
GnRH Antibodies
All 3 cases had titers of antibodies against GnRH (Figure
2). None of the controls had any antibodies (cut off: 0.800
optical densities).
CD40 and CRP
The concentration of sCD40 correlated positively to the
levels of GnRH antibodies (Figure 2), whereas CRP (2, 2
and 29 mg/L, respectively) did not correlate either to
sCD40 or to antibodies (rs = 0.866, p < 0.33 for both).
Figure 1 Control myenteric ganglia. A: one GnRH positive neuron 
(thick arrow) and two GnRH negative neurons within the ganglion. 
(GnRH immunohistochemistry; bar: 20 μm). B: three GnRH receptor 
positive neurons (thin arrows) and three receptor negative nerve cells 
(thick arrows) in control ganglion. (GnRH receptor immunohistochem-
istry; bar: 20 μm).
A BOhlsson et al. BMC Gastroenterology 2010, 10:48
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Cell culture
Myenteric neurons were seeded and grown for 4 days
before the addition of the sera or buserelin. The density of
myenteric neurons at 4 DIV was 8.9 ± 0.5/mm2 (n = 14).
The cultured myenteric neurons stained well with anti-
bodies against PGP 9.5 and were thus easily distinguish-
able (Figure 3). The neurons were uniformly dispersed
throughout the culture well. They often grouped into
clusters containing 4-12 neurons and possessed a rich
network of arborising fibers, frequently connecting other
neurons.
Addition of serum from case 3 to cultures of myenteric
neurons significantly and concentration-dependently
reduced neuronal survival; at the highest concentration
(1:100) 59.4 ± 4.2% of the neurons survived as compared
to controls run in parallel in the absence of the serum.
Addition of sera from case 1 and 2 or control sera from 3
different, healthy blood donors did not affect neuronal
survival. The results are summarised in Figures 4.A-D.
The presence of antiserum against GnRH raised in rab-
bit did not affect the survival of myenteric neurons in cul-
ture (Figure 4.E). The presence of buserelin resulted in a
concentration-dependent increase in neuronal survival as
compared to neurons cultured in medium without buser-
elin (Figure 4.F). The highest buserelin concentration
tested resulted in a markedly enhanced neuronal survival,
168 ± 13% as compared to controls run in parallel (100%).
Histopathology
Case 1 was examined by a full-thickness biopsy. The
mucosa, submucosa, and smooth muscle cells showed no
pathologic alterations. Within the submucous ganglia the
number of GnRH+ neurons was diminished to 23% com-
pared to 72 ± 8% in the controls.
Many myenteric neurons were swollen (>50 μm), pale
and often vacuolised showing chromatolysis; whereas a
few enlarged neurons had an "oxyphilic-appearance" (Fig-
ure 5A). "Hyaline bodies" were observed within and at the
ganglia (Figure 5B). The counting of GnRH+/- neurons
revealed 28% positive myenteric neurons in the patient
versus 62 ± 10% in the controls. The immunostaining for
GnRH receptor was positive in 26% myenteric neurons in
the patient compared to 46 ± 6% in the controls. Intran-
eural CD3+ T-lymphocytes were observed both within
the large nerve bundles and the myenteric ganglia close to
neurons (Figure 5C). About 90% of these T-cells were
CD8+. Some of the small intra-muscular nerves showed
axon vacuolation with CD3+/8+ lymphocytes along these
nerves (Figure 5D-E). The immunostainings for herpes
type 1 and 2 were negative. Based upon these features,
the pathological diagnosis was ganglioneuritis, combined
with decrease of GnRH and GnRH receptor positive neu-
rons.
T h e  n u m b e r  o f  I C C s  i n  t h e  c i r c u l a r  m u s c l e s  w a s
slightly increased: 19 ICCs/1 mm2 muscle versus 14 in
controls, whereas it was normal in the intermyenteric
plexus. The ICCs showed normal cytomorphology.
Discussion
These 3 cases had in common symptoms of nausea, vom-
iting and abdominal pain and all had antibodies against
GnRH in serum, although none had received GnRH or its
analogues. Notably, histopathological examination of
Figure 3 Immunocytochemical staining with PGP of myenteric 
neurons grown for 6 days. The cultured neurons survive well; they 
group into ganglion-like structures and grow a prominent arborising 
network of nerve terminals. Bar 40 μm.
Figure 2 The correlation between the concentration of antibod-
ies against gonadotropin releasing hormone (GnRH) at 1:40 dilu-
tion and soluble CD40 in serum (pg/ml), rs = 1.000, p < 0.01. The 
measured absorbance at 405 nm of different plasma samples using the 
ELISA procedure described was transformed to the corresponding rab-
bit anti-GnRH with the aid of the standard curve. The sample was con-
sidered as positive if the absorbance was > 0.800.
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case 1 showed ganglioneuritis and neuron degeneration
combined with a decrease in the number of GnRH and
GnRH receptor positive neurons in the full-thickness
ileum biopsy. Case 1 had relapses of herpes simplex infec-
tions, and it has been demonstrated in rats that herpes
simplex viruses are stored in myenteric ganglia of the gas-
trointestinal tract [16]. A connection between cytomega-
loviruses and the development of CIPO by direct viral
infection and inflammation of the myenteric ganglia has
been described [17]. Therefore, one could suggest that
viral damage to the nerves leads to exposure of GnRH
and to the development of antibodies against GnRH [18].
In the present study, at the time of the biopsy, no herpes-
viral antigens could be detected in the bowel wall and
there was no histological sign of cytomegalovirus infec-
tion.
It is important to notify, that there was a difference
regarding the histological findings between case 1 and the
previously reported woman who developed GnRH anti-
bodies after buserelin treatment and in vitro fertilization
(IVF) [5]. The latter developed degeneration of the myen-
teric neurons and severe loss of GnRH positive neurons
without lymphocytic ganglioneuritis [5], while case 1 had
ganglioneuritis. This may be explained either by the fact
that she was biopsied in an earlier stage of the process
than case 1, or by missing the foci of ganglioneuritis in
the previous reported case due to uneven and focal distri-
bution of the lymphocytic attack on the myenteric gan-
glia. In healthy controls, there was described a higher
a m o u n t  o f  G n R H  t h a n  G n R H  r e c e p t o r s .  T h i s  m a y
depend on down-regulation of the receptor due to stimu-
lation. This discrepancy was not seen in the case.
Previous studies have described the presence of autoan-
tibodies against neuronal structures in CIPO, especially
as secondary to malignancy [19], but this is the first time
that such antibodies have been found in patients suffering
Figure 4 Neuronal survival of neurons pre-cultured for 4 days followed by 2 days of culture in the presence of (A) serum from case 3 (n = 
5), (B) serum from case 1 (n = 8), (C) serum from case 2 (n = 3), (D) serum from healthy blood donors (n = 8), (E) gonadotropin-releasing 
hormone (GnRH) antibodies raised in rabbit (n = 6-7) and (F) buserelin (n = 8). Addition of sera from cases number one and two, from healthy 
blood donors or GnRH antibodies caused no change in neuronal survival while serum from case 3 significantly and concentration-dependently re-
duced neuronal survival. Buserelin markedly enhanced neuronal survival in a concentration-dependent manner. *** p < 0.01, as compared to the con-
trols run in parallel.
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from IBS or diabetes mellitus. A new classification of dys-
motility diseases based upon the etiology has been dis-
cussed instead of the symptomatology as today [12].
Although the patients of the present report expressed dif-
ferent clinical findings, there may be a common etiologi-
cal factor on the molecular basis, leading to different
clinical expression. We have earlier described the pres-
e n c e  o f  G n R H  i n  t h e  h u m a n  e n t e r i c  n e r v o u s  s y s t e m
(ENS) [5]. In rats, GnRH and GnRH receptor mRNA has
been found in the myenteric plexus [20,21]. The effect on
the ENS is not completely evaluated, but GnRH has been
shown to inhibit the release of gastric secretions and gas-
trin release in dog [22], to stimulate motor function in the
gastrointestinal tract in female rats [6,7] and to restore
motor function in a patient suffering from CIPO [17].
The reason for the development of GnRH antibodies
and their biological role in the 3 studied cases is not
known. Indeed, in all cases the titer of anti-GnRH anti-
bodies correlated to the plasma level of sCD40, which is
related to the CD40 expression and the activity of the
CD40-CD40L signalling pathway. CD40 is a 45-50 kDa
type I transmembrane protein which belongs to the TNF
receptor superfamily and it is expressed on the surface of
numerous immune and non-immune cells. The CD40 is
an important signalling pathway in the initiation and
maintenance of immune responses, including those asso-
c i a t e d  w i t h  c h r o n i c  i n f l a m m a t o r y  d i s e a s e s  [ 3 ] .  F o r
instance, in autoimmune diseases such as Grave's disease
and Hashimoto's thyreoiditis, CD40 seems to be a marker
of the active stage of the diseases [4]. Increased plasma
levels of sCD40 and their correlation with the extent of
m u c o s a l  i n f l a m m a t i o n  h a v e  b e e n  r e c e n t l y  r e p o r t e d  i n
patients with inflammatory bowel disease [23].
Based on the finding that the titers of anti-GnRH anti-
bodies correlate with sCD40 levels, we hypothesized that
in our studied cases GnRH antibodies may be related to
neuronal damage. To test the hypothesis that anti-GnRH
antibodies can directly cause neuronal damage, we cul-
tured rat myenteric neurons in primary cell culture and
m eas u r ed  c e l l  via b i l i t y  a ft e r  2  da ys  e x pos u r e  t o  s e ru m
from cases 1, 2 and 3. Case 3 was in an active inflamma-
tory stage reflected by high anti-GnRH antibody titer and
high plasma concentrations of sCD40 and CRP, and addi-
tion of serum from case 3 to cultured rat myenteric neu-
rons caused remarkable cell death. In contrast, serum
from cases 1 and 2 having lower anti-GnRH antibody
titer and lower sCD40 levels had no significant effect on
neuronal viability. Sera from other diabetic patients, with
or without gastroparesis and acute inflammation, but
without GnRH antibodies, did not destroy cultured
myenteric neurons (unpublished data).
To in further detail study the effect of anti-GnRH anti-
body on neuronal viability, we exposed neuronal cultures
to various concentrations of purified commercial anti-
GnRH antibody. However, under our experimental condi-
tions, anti-GnRH antibody per se showed no effect on
neuronal viability. The finding that buserelin, a long-act-
ing GnRH analogue, increased neuronal viability was
really unexpected which since in the pituitary, GnRH and
its agonists act as functional antagonists when adminis-
tered continuously [24]. Similar desensitization may also
occur in other GnRH target cells. Thus, increased neu-
ronal survival in this system may very well have occurred
in the presence of downregulated GnRH receptor-cou-
pled signaling pathways. This latter result also leads to
speculation that reduction of the GnRH concentration
due to autoantibody generation against GnRH in the
bowel wall may initiate neuron degeneration.
Indeed, interpretation of our data in terms of a biologi-
cal role on anti-GnRH is somewhat complicated by the
fact that serum from cases 1 and 2 did not induce neu-
ronal death in vitro. Currently, one can only speculate
that anti-GnRH toxicity may be dependent on antibody
heterogeneity, as described, for example, in atherosclero-
sis [25] or other factors, in addition to auto antibodies,
are necessary to be present to amplify or execute neuro-
degenerative effects. On the other hand, the GnRH anti-
Figure 5 Details of a myenteric ganglion and surrounding muscle 
tissue. 5A. The cytoplasm of the enlarged neuron is filled with small 
tightly packed eosinophilic granules, the nucleus is compressed, elon-
gated (large arrow). There are two other neurons with vacuolized cyto-
plasm (double arrows) and another small, shrunken neuron (short 
arrow) (Haematoxylin & eosin;bar: 20 μm). 5B. Eosinophilic residual 
body with shadows of vacuoles of a necrotic neuron (large arrow). The 
double arrows show a degenerating neuron containing very large nu-
cleolus and extremely pale cytoplasm with a few perinuclear vacuoles. 
(Haematoxylin & eosin; bar: 20 μm). 5C. Ten μm large, activated T-lym-
phocytes in the vicinity of two neurons (arrows). (CD3 immunohis-
tochemistry; bar: 20 μm). 5D and E show detail of the circular muscle 
with a small nerve as followed up on serial sections. 5D. There is a small 
cell containing a densely stained rounded nucleus (arrow) along the 
small nerve. (Neurofilament immunohistochemistry; bar: 20 μm). 5E. 
Several CD3+ T-lymphocytes are seen along the nerve shown on 5D. 
(CD3 immunohistochemistry; bar: 20 μm).Ohlsson et al. BMC Gastroenterology 2010, 10:48
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bodies may be secondary to neuron degeneration and
subsequent exposure of neuron material to inflammatory
cells.
The answer on these questions would be a significant
step forward in better understanding pathology of gastro-
intestinal dysmotility.
Conclusion
Here we have described the presence of autoantibodies
against GnRH and reduction of GnRH and its receptor in
enteric neurons in one patient with gastrointestinal com-
plaints. Further, serum from one patient with antibodies
and acute inflammation destroyed rat neurons in culture
at the same time as GnRH exerted a neuron-protective
effect. The associations between these different findings
have to be settled. Development of autoantibodies against
GnRH may be related to neuron degeneration and gastro-
intestinal symptoms in a subgroup of patients, but this
warrants further research.
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